Landmark Privacy Proposal To Give Consumers Control Over Their Genetic Data Advances To Governor Newsom’s Desk For Signature
By George Thomas,
The Government Center Gazette [cites CGS]
| 09. 01. 2020
SACRAMENTO, CA — Senator Thomas J. Umberg (D-Santa Ana) announced today that his measure, Senate Bill 980 (SB 980) passed the California State Assembly and will soon go to the desk of Governor Gavin Newsom to be signed into law. SB 980 would assure consumers that Direct-to-Consumer (DTC) genetic testing companies will use their genetic data solely for the purposes to which they have consented. This bill has support from various privacy and consumer groups, including the American Civil Liberties Union (ACLU), Electronic Frontier Foundation, Consumer Reports, Consumer Action, and Privacy Clearing House, and the Center for Genetics and Society.
“At-home DNA tests have provided people with the ability to seek meaningful connections to long-lost families or their own cultural and religious histories. Most people have no idea that this data can then legally be shared with third parties or potentially used against them in a variety of ways” said Senator Umberg “Genetic testing companies have, to date, gone largely unregulated by either state or national governments. This has led to breaches of sensitive private biological information and a suggestion by even the United...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...